Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00638222 · ClinicalTrials.gov registry record · NA
Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease
A NA study, sponsored by University of Toledo Health Science Campus.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT00638222: Clinical Trial NA study, sponsored by University of Toledo Health Science Campus.
NCT00638222 is a NA study that was terminated before completion, run by University of Toledo Health Science Campus. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00638222, a NA study, was terminated before completion, sponsored by University of Toledo Health Science Campus.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Evaluate effectiveness of Carvedilol CR on Micro T-Wave Alternans in high risk hypertensives
Interventions
- OTHER Carvedilol and Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-12 |
| Phase | NA |
Why NCT00638222 stopped before completion
NCT00638222 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Carvedilol and Placebo is the first listed.
NCT00638222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00638222 about?
NCT00638222 is a clinical study titled "Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease". Evaluate effectiveness of Carvedilol CR on Micro T-Wave Alternans in high risk hypertensives
What is the current status of trial NCT00638222?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2008-05. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00638222?
The interventions under investigation include: Carvedilol and Placebo (OTHER).
Who is sponsoring clinical trial NCT00638222?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00638222's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia